Literature DB >> 9636164

Arachidonic acid mediates angiotensin II effects on p21ras in renal proximal tubular cells via the tyrosine kinase-Shc-Grb2-Sos pathway.

H Jiao1, X L Cui, M Torti, C H Chang, L D Alexander, E G Lapetina, J G Douglas.   

Abstract

In kidney epithelial cells, an angiotensin II (Ang II) type 2 receptor subtype (AT2) is linked to a membrane-associated phospholipase A2 (PLA2) and the mitogen-activated protein kinase (MAPK) superfamily. However, the intervening steps in this linkage have not been determined. The aim of this study was to determine whether arachidonic acid mediates Ang II's effect on p21ras and if so, to ascertain the signaling mechanism(s). We observed that Ang II activated p21ras and that mepacrine, a phospholipase A2 inhibitor, blocked this effect. This activation was also inhibited by PD123319, an AT2 receptor antagonist but not by losartan, an AT1 receptor antagonist. Furthermore, Ang II caused rapid tyrosine phosphorylation of Shc and its association with Grb2. Arachidonic acid and linoleic acid mimicked Ang II-induced tyrosine phosphorylation of Shc and activation of p21ras. Moreover, Ang II and arachidonic acid induced an association between p21ras and Shc. We demonstrate that arachidonic acid mediates linkage of a G protein-coupled receptor to p21ras via Shc tyrosine phosphorylation and association with Grb2/Sos. These observations have important implications for other G protein-coupled receptors linked to a variety of phospholipases.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9636164      PMCID: PMC22636          DOI: 10.1073/pnas.95.13.7417

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Relationship between phospholipase C activation and prostaglandin E2 and cyclic adenosine monophosphate production in rabbit tubular epithelial cells. Effects of angiotensin, bradykinin, and arginine vasopressin.

Authors:  C Welsh; G Dubyak; J G Douglas
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

2.  Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation.

Authors:  S E Egan; B W Giddings; M W Brooks; L Buday; A M Sizeland; R A Weinberg
Journal:  Nature       Date:  1993-05-06       Impact factor: 49.962

3.  Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor.

Authors:  L Buday; J Downward
Journal:  Cell       Date:  1993-05-07       Impact factor: 41.582

4.  Differential regulation of rasGAP and neurofibromatosis gene product activities.

Authors:  G Bollag; F McCormick
Journal:  Nature       Date:  1991-06-13       Impact factor: 49.962

5.  Phosphorylation and activation of a high molecular weight form of phospholipase A2 by p42 microtubule-associated protein 2 kinase and protein kinase C.

Authors:  R A Nemenoff; S Winitz; N X Qian; V Van Putten; G L Johnson; L E Heasley
Journal:  J Biol Chem       Date:  1993-01-25       Impact factor: 5.157

6.  cPLA2 is phosphorylated and activated by MAP kinase.

Authors:  L L Lin; M Wartmann; A Y Lin; J L Knopf; A Seth; R J Davis
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

7.  Ras activation by insulin and epidermal growth factor through enhanced exchange of guanine nucleotides on p21ras.

Authors:  R H Medema; A M de Vries-Smits; G C van der Zon; J A Maassen; J L Bos
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

8.  Epidermal growth factor regulates the exchange rate of guanine nucleotides on p21ras in fibroblasts.

Authors:  L Buday; J Downward
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

9.  Angiotensin II receptor subtypes in cultured rat renal mesangial cells.

Authors:  P Ernsberger; J Zhou; T H Damon; J G Douglas
Journal:  Am J Physiol       Date:  1992-09

10.  Requirement for c-ras proteins during viral oncogene transformation.

Authors:  M R Smith; S J DeGudicibus; D W Stacey
Journal:  Nature       Date:  1986 Apr 10-16       Impact factor: 49.962

View more
  7 in total

Review 1.  Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease?

Authors:  Philip Rosenstiel; Stefan Gallinat; Alexander Arlt; Thomas Unger; Jobst Sievers; Ralph Lucius
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

2.  Oxidative signaling in renal epithelium: Critical role of cytosolic phospholipase A2 and p38(SAPK).

Authors:  Xiao-Lan Cui; Yaxian Ding; Larry D Alexander; Chengyuan Bao; Otor K Al-Khalili; Michael Simonson; Douglas C Eaton; Janice G Douglas
Journal:  Free Radic Biol Med       Date:  2006-02-28       Impact factor: 7.376

3.  Angiotensin II stimulates fibronectin protein synthesis via a Gβγ/arachidonic acid-dependent pathway.

Authors:  Larry D Alexander; Yaxian Ding; Suganthi Alagarsamy; Xiaolan Cui
Journal:  Am J Physiol Renal Physiol       Date:  2014-06-11

4.  Ca(2+)-dependent activation of c-jun NH(2)-terminal kinase in primary rabbit proximal tubule epithelial cells.

Authors:  X L Cui; W W Jin; Y X Ding; L D Alexander; U Hopfer; J G Douglas
Journal:  Am J Physiol Cell Physiol       Date:  2000-08       Impact factor: 4.249

5.  Angiotensin II stimulates cyclic ADP-ribose formation in neonatal rat cardiac myocytes.

Authors:  H Higashida; J Zhang; M Hashii; M Shintaku; C Higashida; Y Takeda
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

6.  Roles of ERK and cPLA2 in the angiotensin II-mediated biphasic regulation of Na+-HCO3(-) transport.

Authors:  Yuehong Li; Hideomi Yamada; Yoshihiro Kita; Motoei Kunimi; Shoko Horita; Masashi Suzuki; Yoko Endo; Takao Shimizu; George Seki; Toshiro Fujita
Journal:  J Am Soc Nephrol       Date:  2007-12-19       Impact factor: 10.121

7.  Phospholipase A2-mediated activation of mitogen-activated protein kinase by angiotensin II.

Authors:  N O Dulin; L D Alexander; S Harwalkar; J R Falck; J G Douglas
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.